Key result
Transseptal chordal replacement is an emerging transcatheter technique for treating primary mitral regurgitation, with multiple devices currently in early preclinical or first-in-human development stages.
Why the study?
Surgical chordal replacement requires an open, non-beating heart and challenging chord sizing, motivating transcatheter transseptal approaches that allow real-time adjustment on a beating heart.
Transcatheter transseptal approaches to mitral valve chordal replacement offer the potential for real-time adjustment on a beating heart, presenting a safer and potentially earlier treatment option for primary mitral regurgitation.
Answers are grounded in this paper and cite their sources.
Transseptal chordal replacement remains early-stage and investigational for primary MR; leaves open its safety and role pending prospective trials.
Chordal replacement is a fundamental technique used in the surgical repair of primary mitral regurgitation, and can be an effective means of preserving the native valve without leaflet resection. Surgical chordal replacement can be challenging since it is performed on an open, non-beating heart, and choosing the correct chord length to restore the zone of coaptation requires both intuition and skill. Developing transcatheter, transfemoral, and transseptal approaches to mitral valve chordal replacement presents the opportunity for safer and potentially earlier treatment of patients with primary mitral regurgitation. In particular, transcatheter methods will allow adjustment of chordal length and position real-time on a beating heart under echocardiographic guidance. In this manuscript, we review the current transcatheter transseptal technologies in development and discuss the various issues related to device design, efficacy, durability, and clinical trial design.
No takes yet. Share an insight, caveat, or question.
Rogers et al. (2021) conducted a review in Primary mitral regurgitation. Transcatheter transseptal chordal replacement was evaluated. Transseptal chordal replacement is an emerging transcatheter technique for treating primary mitral regurgitation, with multiple devices currently in early preclinical or first-in-human development stages.
Synapse has enriched 10 related papers. Consider them for comparative context: